Empowering personal healthcare.

• $10 million Grand Prize possible
• $4.7 million Prize Purses Awarded
• $5.3 million dedicated to Post-Prize Programs at UCSD and Mozambique
• $1.1 million Additional Milestones were awarded:
  • Lab Test Demonstration Milestone of $50K to 5 teams
  • Human Qualification Milestone of $375K each to 2 teams
  • Bold Epic Innovator Award of $100K to 1 team
    

In virtually every industry, end consumer needs drive advances and improvements. Except in healthcare. Very few methods exist for consumers to receive direct medical care without seeing a healthcare professional at a clinic or hospital, creating an access bottleneck. Despite substantial investment to improve the status quo, even average levels of service, efficiency, affordability, accessibility, and satisfaction remain out of reach for many whom the system was intended to help.

• • Each team has continued to advance innovative devices through clinical testing in the United States, Canada, India, and China.
• • Cloud DX is commercializing their Vitaliti™ Continuous Vital Sign Monitor, a key part of their competition entry. Testing for regulatory approval is underway, with final approvals expected in 2021.
• • Qualcomm Foundation has committed $5.3M in post-prize programs, primarily funding clinical testing at The Altman Clinical and Translational Research Institute (ACTRI) where the devices were tested throughout the competition as well as the development of IT infrastructure to support device data transfer and storage into a cloud environment.
• • The Roddenberry Foundation has committed $1.6M to fund a combined effort in Mozambique and the Qualcomm Institute at UCSD. The AcuScreen™ program is putting innovative Tricorder-based technologies from Cloud DX into the hands of healthcare providers to more rapidly and accurately diagnose Tuberculosis (TB) and hypertension—two significant unmet medical needs throughout Africa. Participating Sites include: Mavalane Health Centre with UPT Unidade de Pesquisa Clinica, Mavalane General Hospital Chronic Non-transmissible Disease Unit, and Clinical Research and Centro de Pesquisa e Investigação em Saúde da Polana Caniço (CISPOC) in Maputo, Mozambique.